美托洛尔治疗糖尿病合并冠心病的临床效果分析  

Clinical Effect of Metoprolol in the Treatment of Diabetes With Coronary Heart Disease

作　　者：邱莉莉 周波[1] 王艳丽 郭梅 张晶 陈敏[1] 施懿哲 QIU Lili;ZHOU Bo;WANG Yanli;GUO Mei;ZHANG Jing;CHEN Min;SHI Yizhe(Department of Endocrinology,Qianjiang Central Hospital of Hubei/Qianjiang Hospital of Wuhan University People's Hospital,Qianjiang Hubei 433100,China)

机构地区：[1]湖北省潜江市中心医院/武汉大学人民医院潜江医院内分泌科,湖北潜江433100

出　　处：《中国继续医学教育》2021年第16期141-144,共4页China Continuing Medical Education

摘　　要：目的分析并探讨美托洛尔应用于糖尿病合并冠心病临床治疗的实际效果。方法选择2014年1月—2019年12月笔者所在医院收治的糖尿病合并冠心病患者共计80例。采用信封法,将80例患者随机分为对照组40例和研究组40例。对照组接受小剂量美托洛尔治疗,研究组接受大剂量美托洛尔治疗,并对两组的临床治疗效果进行比较。结果治疗后,研究组治疗有效率显著高于对照组,P<0.05;研究组血糖指标显著低于对照组,P<0.05。结论临床治疗糖尿病合并冠心病时,适当增加美托洛尔的用药剂量,不仅能增强治疗效果,还能改善患者的血糖指标,值得在临床中应用。Objective The actual effect of metoprolol in the clinical treatment of diabetes and coronary heart disease was analyzed and discussed.Methods A total of 80 diabetic patients with coronary heart disease who were admitted to the hospital of the author from January 2014 to December 2019 were selected.80 patients were randomly divided into a control group and a study group by the envelope method.The control group received low-dose metoprolol,the study group received high-dose metoprolol,and the clinical treatment effects of the two groups were compared.Results After treatment,the treatment group’s treatment efficiency was significantly higher than that of the control group,P<0.05;the blood glucose index of the study group was significantly lower than that of the control group,P<0.05.Conclusion In the clinical treatment of diabetes with coronary heart disease,appropriately increasing the dose of metoprolol can not only enhance the treatment effect,but also improve the patient’s blood glucose index,which is worthy of application in clinical.

关 键 词：美托洛尔 糖尿病 血糖指标 冠心病 临床效果 应用价值 

分 类 号：R587[医药卫生—内分泌]